Loading...
Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma
Rationale: Mepolizumab, an IL-5–blocking antibody, reduces exacerbations in patients with severe eosinophilic asthma. Mepolizumab arrests eosinophil maturation; however, the functional phenotype of eosinophils that persist in the blood and airway after administration of IL-5 neutralizing antibodies...
Na minha lista:
| Udgivet i: | Am J Respir Crit Care Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Thoracic Society
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5736971/ https://ncbi.nlm.nih.gov/pubmed/28862877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201611-2234OC |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|